The Trump administration yesterday began distributing 150 million rapid point-of-care tests for the COVID-19 virus that it purchased in August, which will go to states and territories (100 million), nursing homes (18 million), assisted living facilities (15 million), home health and hospice care agencies (10 million), historically black colleges and universities, and tribal nation colleges.

Abbott Diagnostics plans to make up to 48 million of the BinaxNOW Ag Card antigen tests available monthly in the U.S. in the coming weeks.

The Food and Drug Administration last month authorized laboratories certified to perform moderate, high or waived complexity tests under the Clinical Laboratory Improvement Amendment to use the test to detect SARS-CoV-2 in nasal swabs from individuals whose health care provider suspects they have COVID-19 within seven days of symptom onset.

Negative antigen tests do not need to be repeated or confirmed with a high-sensitivity molecular test when they are employed for routine screening or surveillance,” said Assistant Secretary for Health Admiral Brett Giroir, M.D.

 

Related News Articles

Headline
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce congue lorem nisl, ac dapibus dui vestibulum ut. Vivamus egestas at ipsum eget posuere.…
Headline
Moderna Inc. today announced that its mRNA-1273 vaccine candidate against COVID-19 is 94.5% effective, according to early data. The candidate is currently…
Headline
As of Nov. 6, about 60% of the nation’s retail pharmacies have agreed to participate in a federal program to administer COVID-19 vaccines at no cost to…
Perspective
“Don’t let perfect be the enemy of the good” is a quote credited to the French writer and thinker Voltaire. Although he died in 1778, that phrase is very…
Headline
To continue amplifying the important message of protecting against both the flu and COVID-19, AHA’s Wear A Mask and United Against the Flu campaigns today…
Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response has released guidance on considerations for health…